MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

2-day In-person Seminar on Understanding FDA and Avoiding Inspections Leading to Warning Letters, Seizures, Injunctions and Prosecutions at Minneapolis

Event Details

2-day In-person Seminar on Understanding FDA and Avoiding Inspections Leading to Warning Letters, Seizures, Injunctions and Prosecutions at Minneapolis

Time: June 5, 2014 at 9am to June 6, 2014 at 6pm
Location: WILL BE ANNOUNCED SOON
Street: Minneapolis, MN
City/Town: Minneapolis
Website or Map: http://bit.ly/1lZNFJO
Phone: 18004479407
Event Type: seminar, pharma, medical, clinical, health, compliance, regulatory, fda
Organized By: GlobalCompliancePanel
Latest Activity: May 9, 2014

Export to Outlook or iCal (.ics)

Event Description

Overview:

FDA inspections are typically the starting point for the sequence of enforcement actions, since serious violations discovered at inspections will often result in Warning Letters, which in turn, if not properly responded to, can turn into seizures, injunctions, prosecutions, or recalls or consent decrees. So you can look at the number of inspections as one indicator of how aggressive FDA is being regarding enforcement. 

Why should you attend?
  • Address different types of Warning Letters
  • Understanding FDA's enforcement strategy and what it means to your firm
  • Understanding how auditors think and their expectations
  • Being prepared to receive regulatory inspections
  • Recognizing when inspectional findings or events indicate potential regulatory actions
  • When to take or not immediate action during an inspection

Who Will Benefit:

  • Individuals who come in contact with regulatory inspectors
  • Auditors
  • Compliance/Regulatory affairs professionals
  • QA/QC professionals
  • Senior management executives (CEO, COO, CFO, etc.)
  • Manufacturing managers, supervisors & personnel
  • Project Managers
  • Regulatory Affairs Management
  • Regulatory Affairs Specialist

 

About Speaker: 

David R. Dills

Regulatory Affairs & Compliance Consultant, 

 

David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry, has an extensive regulatory and compliance background with Class I/II/III and IVD devices, pharmaceutical operations, and manages activities within the global regulatory and compliance space. 

DATE, VENUE & PRICE:

Location1: Location: Minneapolis        Date: June 5th & 6th 2014        Time: 9 AM to 6 PM CDT 

Venue: WILL BE ANNOUNCED SOON

 

Location2: Location: Boston        Date: July 10th & 11th 2014        Time: 9 AM to 6 PM EDT 

 

Price: $1,295.00

 

Register now and save $200. (Early Bird)

Until April 30, Early Bird Price: $1,295.00

From May 01 to June 03, Regular Price: $1,495.00

 

Contact Information:

 

Event Coordinator

Toll free: 1800 447 9407

Fax: 302 288 6884

Email: support@globalcompliancepanel.com

Website: https://www.globalcompliancepanel.com

LIVE CHAT SUPPORT ALSO - http://www.globalcompliancepanel.com/chat/client.php

Event Link - http://bit.ly/1lZNFJO

GlobalCompliancePanel

 

Net Zealous LLC,

DBA GlobalCompliancePanel

161 Mission Falls Lane,

Suite 216, Fremont, CA 94539, USA

Comment Wall

Comment

RSVP for 2-day In-person Seminar on Understanding FDA and Avoiding Inspections Leading to Warning Letters, Seizures, Injunctions and Prosecutions at Minneapolis to add comments!

Join MedTech I.Q.

Attending (1)

© 2024   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service